Login Server Home  |  XIG Home  |  XIG Stats  | 

FHIRsmith Logo FHIR IG analytics

Packagede.medizininformatikinitiative.kerndatensatz.molgen
Resource TypeServiceRequest
IdServiceRequest-mii-exa-molgen-anforderung-fgfr2-fusion.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: ServiceRequest mii-exa-molgen-anforderung-fgfr2-fusion

Profile: MII PR MolGen Anforderung genetischer Test version: 2027.0.0-ballot.1

identifier: https://www.charite.de/fhir/auftragsnummern/PRK4QE59A

status: Active

intent: Order

category: Laboratory procedure (procedure)

code: Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom

subject: Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))

authoredOn: 2022-11-30

requester: Practitioner Dr. Linda Rubens(official)

reasonCode: Intrahepatic bile duct carcinoma (disorder)


German


Generated Narrative: ServiceRequest mii-exa-molgen-anforderung-fgfr2-fusion

Profile: MII PR MolGen Anforderung genetischer Test version: 2027.0.0-ballot.1

identifier: https://www.charite.de/fhir/auftragsnummern/PRK4QE59A

status: Active

intent: Order

category: Laboratory procedure (procedure)

code: Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom

subject: Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))

authoredOn: 2022-11-30

requester: Practitioner Dr. Linda Rubens(official)

reasonCode: Intrahepatic bile duct carcinoma (disorder)


Source

{
  "resourceType": "ServiceRequest",
  "id": "mii-exa-molgen-anforderung-fgfr2-fusion",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/anforderung-genetischer-test|2027.0.0-ballot.1"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "identifier": [
    {
      "system": "https://www.charite.de/fhir/auftragsnummern",
      "value": "PRK4QE59A"
    }
  ],
  "status": "active",
  "intent": "order",
  "category": [
    {
      "coding": [
        {
          "system": "http://snomed.info/sct",
          "code": "108252007",
          "display": "Laboratory procedure (procedure)"
        }
      ]
    }
  ],
  "code": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "405825005",
        "display": "Molecular genetic test (procedure)"
      }
    ],
    "text": "Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom"
  },
  "subject": {
    "reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
  },
  "authoredOn": "2022-11-30",
  "requester": {
    "reference": "Practitioner/mii-exa-molgen-practitioner-physician"
  },
  "reasonCode": [
    {
      "coding": [
        {
          "system": "http://snomed.info/sct",
          "code": "109842005",
          "display": "Intrahepatic bile duct carcinoma (disorder)"
        },
        {
          "system": "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
          "version": "2024",
          "code": "C22.1",
          "display": "Intrahepatisches Gallengangskarzinom"
        }
      ]
    }
  ]
}